Galera Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Galera Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $6.38 million for the year ending 2025.

  • Galera Therapeutics, Inc. showed a decrease of -23.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Galera Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Galera Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 57.0%.
  • Historical annual values: Fiscal year 2025: $6.38 million | Fiscal year 2024: $8.29 million | Fiscal year 2023: $18.26 million | Fiscal year 2022: $4.27 million | Fiscal year 2021: $19.86 million | Fiscal year 2020: $15.87 million | Fiscal year 2019: $18.36 million | Fiscal year 2018: $14.81 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: